Details of the Drug

General Information of Drug (ID: DMEH8I0)

• Drug Name: 16-(4-dimethylamino-benzylidene)-estradiol
• Synonyms: SCHEMBL12379373

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 1:
  Molecular Weight (mw); 403.6
  Logarithm of the Partition Coefficient (xlogp); 5.3
  Rotatable Bond Count (rotbonds); 2
  Hydrogen Bond Donor Count (hbonddonor); 2
  Hydrogen Bond Acceptor Count (hbondacc); 3
• Chemical Identifiers:
  Formula: C27H33NO2
  IUPAC Name: (13S,16E,17S)-16-[[4-(dimethylamino)phenyl]methylidene]-13-methyl-7,8,9,11,12,14,15,17-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
  Canonical SMILES: C[C@]12CCC3C(C1C/C(=C\\C4=CC=C(C=C4)N(C)C)/[C@@H]2O)CCC5=C3C=CC(=C5)O
  InChI: InChI=1S/C27H33NO2/c1-27-13-12-23-22-11-9-21(29)15-18(22)6-10-24(23)25(27)16-19(26(27)30)14-17-4-7-20(8-5-17)28(2)3/h4-5,7-9,11,14-15,23-26,29-30H,6,10,12-13,16H2,1-3H3/b19-14+/t23?,24?,25?,26-,27-/m0/s1
  InChIKey: HUZDSTZYTXBRMO-BACVCVEMSA-N
• Cross-matching ID:
  PubChem CID: 44407495
  TTD ID: D0HR7O

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1)	TTIWB6L	DHB1_HUMAN	Inhibitor	[1]

References

• [1] Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1. J Med Chem. 2006 Feb 23;49(4):1325-45.